Management of hemosiderosis complicated by coexistent anemia with recombinant human erythropoietin and phlebotomy.

Abstract

Patients with hemosiderosis who also suffer from coexistent anemia may be unable to tolerate frequent phlebotomies needed for depletion of body iron stores. Chelation therapy, an alternative approach, may be unsuitable for some patients due to allergic reactions, poor response or intolerance of long-duration subcutaneous administration. The use of recombinant human erythropoietin in such patients could increase the hematocrit and improve exercise tolerance allowing for more frequent phlebotomies. We report the successful use of this combined approach in two such patients.

Statistics

05001000'00'02'04'06'08'10'12'14'16
Citations per Year

177 Citations

Semantic Scholar estimates that this publication has 177 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Bilgrami1993ManagementOH, title={Management of hemosiderosis complicated by coexistent anemia with recombinant human erythropoietin and phlebotomy.}, author={Syed Fazil Bilgrami and Angelica Bartolomeo and V Synnott and Frederick R. Rickles}, journal={Acta haematologica}, year={1993}, volume={89 3}, pages={141-3} }